RPT-CORRECTED-BRIEF-Orion and Sun settle patent dispute

(Repeats to more subscribers) (Corrects Sun Reuters Instrument Code to SUN.BO from SUNH.O)

Healthcare

HELSINKI June 22 (Reuters) – Orion Oyj (ORNBV.HE):

* Says it has settled patent dispute with Sun Pharmaceutical Industries Limited (SUN.BO)

* Says the settlement agreement relates to all lawsuits

* Says according to the agreement Sun will be able to launch generic versions of Parkinson’s drugs Stalevo in 2012 and Comtan in 2013 in the United States

* Says Orion will supply said generic product versions to Sun

CORRECTED-BRIEF-Orion and Sun settle patent dispute

(Corrects Sun Reuters Instrument Code to SUN.BO from SUNH.O)

Healthcare

HELSINKI June 22 (Reuters) – Orion Oyj (ORNBV.HE):

* Says it has settled patent dispute with Sun Pharmaceutical Industries Limited (SUN.BO)

* Says the settlement agreement relates to all lawsuits

* Says according to the agreement Sun will be able to launch generic versions of Parkinson’s drugs Stalevo in 2012 and Comtan in 2013 in the United States

* Says Orion will supply said generic product versions to Sun

Single gene behind essential tremor, Parkinson’s disease identified

Washington, September 2 (ANI): A single gene promotes development of essential tremor in some patients and Parkinson’s disease in others has been identified by an international team of researchers.

In a study report published in Parkinsonism and Related Disorders, Mayo Clinic researchers in Florida and their collaborators worldwide note that patients with essential tremor shake when they move, while those with Parkinson’s disease shake when they are at rest.

They further state that a variant in LINGO1, a gene involved in neuronal survival, is the first proven evidence of a common genetic component in the development of both disorders.

Analysing their findings, the researchers have come to the conclusion that mutations in this gene are potentially responsible for five percent of patients with Parkinson’s disease, and five percent of patients with essential tremor.

Lead researcher Dr. Carles Vilarino-Guell, of Mayo Clinic, said: “There is a mutation in the gene that must be causing or contributing to Parkinson’s disease in some people and essential tremor in others.”

He, however, added that that did not mean that people with essential tremor have an increased risk of developing Parkinson’s disease.

The findings are intriguing because “although essential tremor and Parkinson’s disease are considered to be different diseases, researchers have been arguing for a long time about whether essential tremor is a milder, preliminary form of Parkinson’s disease, and they have been looking for the genetic connection between these disorders,” he said.

“Now we know LINGO1 is the first gene identified,” he added.

The scientists have yet to identify any specific mutation or mutations on LINGO1 responsible for either disorder.

“The easiest explanation is that there are two separate and clearly distinct mutations in the gene contributing to the disorders. But because this gene doubles the risk of developing either disease and it is found at the same frequency in both diseases, it is possibly the same mutation,” Dr. Vilarino-Guell said.

“Both diseases are also affected by environmental factors, and that may influence which disorder a person would be more likely to develop,” he added. (ANI)

Muhammad Ali given huge Irish hero’s welcome

Belfast (Ireland), Sep.2 (ANI): Former World Heavyweight Champion Muhammad Ali was given an Irish hero’s welcome on Tuesday at Turnpike Road from where his great-grandfather Abe Grady set out for the New World almost 150 years ago.

The former three times world heavyweight boxing champion was welcomed like a returning prodigal son when he arrived in Ennis, Co Clare, and was made its first Freeman.

Clearly moved by the fervour of the welcome, he refused to be ushered into a waiting vehicle by his security guards as the crowds chanted: “Ali! Ali! Ali!”

After unveiling a monument near the spot where his ancestral home – a two-room thatched cottage – once stood, he walked with his wife, Yolanda, to meet his fans, the majority of whom were not even born when his brilliant career was dimmed by the onset of Parkinson’s disease, reports The Times.

Today Turnpike Road is lined with primly neat council houses, none prouder than the home of the late Eileen O’Grady, whose daughter, Mary, kissed and hugged her famous distant cousin.

Eileen died nine months ago, preferring to keep her association with one of the greatest sportsmen of all time a secret.

Genealogists traced the roots of Ali, formerly Cassius Clay Jr, to Abe Grady through land registry documents, which record that Grady left Ireland in the 1860s from Cappa Harbour in Kilruch, Co Clare. He settled in Kentucky, where he married a freed African-American slave.

Their son also married an African-American and one of the daughters of that union was Odessa Lee Grady, who married Cassius Clay Sr. (ANI)

Novel therapeutic target for Parkinson’s disease identified

Washington, Aug 29 (ANI): Scientists from University of Helsinki Institute of Biotechnology have identified a novel therapeutic target for Parkinson’s disease.

Lead researcher Professor Raimo K. Tuominen and colleagues have identified a growth factor that can be used to halt the progress of damage brought on by a nerve poison, and possibly restore the function of damaged cells.

The team is investigating two new nerve growth factors. MANF (mesencephalic astrocyte-derived neurotrophic factor) and CDNF.

MANF is released from glial cells in the midbrain and is a member of the same growth factor family as CDNF.

The team found that in the experimental PD model, MANF and CDNF injections into the brain prevented dopamine nerve destruction caused by nerve poison and to some extent even restored the function of damaged cells in rats.

This suggests that MANF spreads more readily in brain tissue than other known growth factors.

This may be a highly significant finding in respect to the development of growth factor therapy for PD. (ANI)

Novel method to make safer human stem cells uses just one gene

London, Aug 29 (ANI): Inching closer to curing diseases like Parkinson’s using cells generated from a patient’s own body, researchers have successfully reprogrammed human nerve cells back to an embryo-like state by using just a single gene.

It is known that embryonic stem cells are pluripotent – they can develop into any of the body’s cell types.

But such cells are not available in large numbers, as they can only be harvested from a donated egg or embryo, and, for ethical reasons, most countries have laws restricting their use.

In 2006, Shinya Yamanaka and his colleagues at Kyoto University in Japan successfully made mouse cells pluripotent by reprogramming skin cells into a state like embryo cells.

They did so by using retroviruses to insert four genes – known as “factors” – into the cells’ DNA.

They repeated the trick a year later with human cells.

However, using genes and retroviruses in this way increases the risk of the cell becoming cancerous, not just because tinkering with DNA has that effect, but also because two of the four factors are known to cause cancer.

In a bid to make these promising cells in a safe way, Hans Scholer’s team at the Max Planck Institute for Molecular Biomedicine in Münster, Germany, has been working to achieve pluripotency using fewer factors.

Last year, they did this with the two factors that do not cause cancer, and now they have simplified the recipe further, doing it with just one.

“Remarkably, it turns out that three of these four essential factors are already expressed in human neural stem cells – although not in skin cells – so we only needed to add one factor, OCT4,” New Scientist quoted Boris Greber, a member of the team, as saying.

He said that the cells from neural tissue are much easier to reprogram than skin cells, and are less prone to mutations.

It is much harder to get a sample of neural stem cells than skin cells, as it can be done via extracting the cells from the dental pulp of teeth, said Greber.

Inserting even one gene into the chromosome of a cell still permanently modifies its DNA, which is why the new method will remain a lab tool instead of being allowed in the clinic.

However, the researchers are hoping that it will help them improve methods for producing embryonic stem cells.

“Ideally, we will be able to find a chemical that does the same job of expressing the factor without the need for a gene,” said Greber.

Earlier this year, researchers in California managed just that when they reprogrammed mouse fibroblasts using a cocktail of proteins.

That technique did not involve inserting genes, and, thus, shouldn’t raise the cancer risk. But that was far less efficient.

“Without stable intervention using viruses, the frequency of reprogramming goes down and you have to wait a long time. We don’t have the perfect method yet,” said Greber.

The study has been published in the journal Nature. (ANI)

Ali visit to Hatton’s health center took him by surprise

London, Aug.27 (ANI): Boxing legend Ricky Hatton admitted his “jaw hit the floor” when he met his all-time hero Muhammad Ali.

Ali, who is fighting Parkinson’s disease, visited Hatton’s health centre in Manchester at the start of a UK tour.

The three-time heavyweight champion of the world, 67, was expected to arrive in a wheelchair, but instead told his aides he wanted to walk into the gym.

The Daily Star quoted the 30-year-old as saying: “A few years ago if you’d said Muhammad Ali would be coming to my local town, Hyde, I’d have said: ‘No way’. You knew it wouldn’t happen. The fact he has put himself out to come to my gym brings a tear to the eye.” (ANI)

New technique to help Parkinson’s patients speak louder

Washington, Aug 26 (ANI): Scientists from Purdue University’s Department of Speech, Language and Hearing Sciences have come up with a novel technique that would help Parkinson’s patients speak louder.

“People with Parkinson’s disease commonly have voice and speech problems,” said Jessica Huber, an associate professor in Purdue’s Department of Speech, Language and Hearing Sciences.

“At some point in their disease they will have some form of voice or speech disorder that generally occurs a little later in the disease,” she added.

The most common therapy, the Lee Silverman voice treatment program, trains patients to speak louder in one-hour sessions four days a week for a month.

“Some Parkinson’s patients do great with this approach, but others do not. They forget to keep speaking louder the minute they have left the therapy room,” said Huber.

Lee Silverman tends to work less for people with later stages of disease or those who have some cognitive decline.

Huber used a new approach: The patients were asked to speak louder while a recording of background “multitalker babble noise” was played. The noise is essentially the sound of a restaurant full of patrons, but without the clattering silverware and clinking glasses.

“They had an easier time getting louder when I had the noise in the room,” she said.

“Ordinarily, when I asked them to be twice as loud they would say they couldn’t. They couldn’t speak 10 decibels louder, but when I turned on the babble noise, they spoke over 10 decibels louder,” she added.

In the device built by engineering resources manager Jim Jones and senior research engineer Kirk Foster, both in the Weldon School, the voice-activated device automatically plays the background babble when the person begins to speak.

A sensor placed on the neck detects that the person has begun to speak and tells the device to play the babble through an earpiece worn by the patient.

“I got the idea that if we train them with a natural cue in their everyday environment, we will probably get better results. We ask them to wear the system for about four hours a day as they go about their daily routine,” she added.(ANI)

Bird flu virus strain leaves survivors at increased Parkinson’s disease risk

Washington, August 20 (ANI): An animal study conducted by experts at St. Jude Children’s Research Hospital has suggested that at least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson’s disease, and possibly other neurological problems later in life.

In their study report, the researchers write that mice that survived infection with an H5N1 flu strain were found to be more likely than uninfected mice to develop brain changes associated with neurological disorders like Parkinson’s and Alzheimer’s diseases.

Parkinson’s and Alzheimer’s involve loss of brain cells crucial to a variety of tasks, including movement, memory and intellectual functioning.

The researchers say that their study has shown that the H5N1 flu strain causes a 17 percent loss of the same neurons lost in Parkinson’s as well as accumulation in certain brain cells of a protein implicated in both diseases.

“This avian flu strain does not directly cause Parkinson’s disease, but it does make you more susceptible,” said Dr. Richard Smeyne, associate member in St. Jude Developmental Neurobiology.

“Around age 40, people start to get a decline in brain cells. Most people die before they lose enough neurons to get Parkinson’s. But we believe this H5N1 infection changes the curve. It makes the brain more sensitive to another hit, possibly involving other environmental toxins,” Smeyne added.

Smeyne revealed that the study focused on a single strain of the H5N1 flu virus, the A/Vietnam/1203/04 strain, and that the threat posed by other viruses, including the current H1N1 pandemic flu virus, was still being studied.

During the study, the researchers infected some mice with an H5N1 flu strain isolated in 2004 from a patient in Vietnam, which is still considered to be the most virulent of the avian flu viruses.

About two-thirds of the mice developed flu symptoms, primarily weight loss. After three weeks, there was no evidence of H5N1 in the nervous systems of the mice that survived.

However, the inflammation triggered by the infection within the brain continued for months, and it was found to be quite similar to inflammation associated with inherited forms of Parkinson’s.

Although the tremor and movement problems disappeared as flu symptoms eased, the researchers reported that 60 days later, mice had lost roughly 17 percent of dopamine-producing cells in SNpc, a structure found in the midbrain.

They also found evidence that the avian flu infection led to over-production of a protein found in the brain cells of individuals with both Alzheimer’s and Parkinson’s diseases.

“The virus activates this protein,” Smeyne said.

The study has been reported in the online early edition of the Proceedings of the National Academy of Sciences. (ANI)

MRI methods can show bone marrow stem cells’ viability as brain-repairing therapy

Washington, August 20 (ANI): Researchers at Tel Aviv University have offered new hope for people with incurable neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s by showing that the viability of stem cells created from a patient’s own bone marrow can be determined using MRI tracking methods.

Dr. Yoram Cohen, of TAU’s School of Chemistry, claims that he has been able to track the progress of the innovative cells called mesenchymal stem cells within the brain.

He says that initial studies indicate that it is possible to identify unhealthy or damaged tissues, migrate to them, and potentially repair or halt cell degeneration.

“By monitoring the motion of these cells, you get information about how viable they are, and how they can benefit the tissue. We have been able to prove that these stem cells travel within the brain, and only travel where they are needed. They read the chemical signalling of the tissue, which indicate areas of stress. And then they go and try to repair the situation,” he says.

During the study, Dr. Cohen and his colleagues tracked the activity of the live cells within the brain using the in-vivo MRI at the Strauss Centre for Computational Neuro-Imaging, with a view to establishing their viability as a therapy for neurodegenerative disease.

The researchers used magnetic iron oxide nanoparticles to label the stem cells, so that they could be identified as clear black dots on an MRI picture after being injected into the brain.

The stem cells were then injected into the brain of an animal that had an experimental model of Huntington’s disease, which suffered from a similar neuropathology as the one seen in human patients.

On MRI, it was possible to watch the stem cells migrating towards the diseased area of the brain.

“Cells that go toward a certain position that needs to be rescued are the best indirect proof that they are live and viable. If they can migrate towards the target, they are alive and can read chemical signalling,” says Dr. Cohen.

He believes that the benefits of using differentiated mesenchymal cells (MSC) may be numerous.

“Bone marrow-derived MSCs bypass ethical and production complications, and in the long run, the cells are less likely to be rejected because they come from the patients themselves. This means you don’t need immunosuppressant therapy,” he says.

Dr. Cohen has revealed that the next step in his research will be to develop a real-life therapy for those suffering from neurodegenerative diseases.

A researcher article on his study has been published in the journal Stem Cells. (ANI)

Muhammad Ali to visit ancestral home in Ireland

London, Aug.9 (ANI): Boxing legend Muhammad Ali is to visit his ancestral Irish home in September.

The former world heavyweight champion has accepted an invitation to see the birthplace of his great-grandfather in Ennis, Co Clare, on September 1, The Telegraph reports.

He is due to visit Dublin for a charity event the previous day

Members of Ennis Town Council are expected to make the 67-year-old, who is fighting Parkinson’s disease, the first Honorary Freeman of Ennis Town during his trip.

Mayor Frankie Neylon said thousands of visitors will come to the town to see the world famous boxer.

Ali’s great-grandfather Abe Grady emigrated from his home on the Turnpike Road in Ennis to the United States in the 1860s.

Grady sailed from Cappa Harbour in Kilrush, Co Clare, eventually settling in Kentucky, where he married an African-American woman.

Their son also married an African-American and one of the daughters of that union was Ali’s mother, named Odessa Lee Grady.

She married Cassius Clay senior, and they settled in Louisville, where their son was initially given his father’s name on his birth in 1942. He later changed his name to Muhammad Ali when he converted to the Nation of Islam after winning the world title in 1964.

Mayor Neylon said further details of Ali’s visit would be finalised during a special meeting of Ennis Town Council on Monday week. (ANI)

Study finds link between pesticide levels in blood and Parkinson’s disease

Washington, July 14 (ANI): In a new study, researchers at UT Southwestern Medical Center have found that people with Parkinson’s disease have significantly higher blood levels of a particular pesticide than healthy people or those with Alzheimer’s disease.

The researchers found the pesticide beta-HCH (hexachlorocyclohexane) in 76 percent of people with Parkinson’s, compared with 40 percent of healthy controls and 30 percent of those with Alzheimer’s.

According to researchers, the finding may provide the basis for a beta-HCH blood test to identify individuals at risk for developing Parkinson’s disease.

The results also point the way to more research on environmental causes of Parkinson’s.There’s been a link between pesticide use and Parkinson’s disease for a long time, but never a specific pesticide. This is particularly important because the disease is not diagnosed until after significant nerve damage has occurred. A test for this risk factor might allow for early detection and protective treatment,” said Dr. Dwight German, professor of psychiatry at UT Southwestern and a senior author of the paper.

The study involved 113 participants, ages 50 to 89. Fifty had Parkinson’s, 43 were healthy and 20 had Alzheimer’s. The researchers tested the subjects’ blood for 15 pesticides known as organochlorines.

These pesticides, which include the well-known DDT, were widely used in the U.S. from the 1950s to the 1970s but are more tightly regulated now. They persist in the environment for years without breaking down.

In the body, they dissolve in fats and are known to attack the type of brain nerves that die in Parkinson’s disease, the researchers said.

The study appears in the July issue of Archives of Neurology. (ANI)

New discovery can help thwart Parkinson’s disease

Washington, July 8 (ANI): Scientists from King’s College London say that blocking the release of chemical glutamate in the brain may help prevent Parkinson’s disease.

Dr. Susan Duty said that one of the contributing factors to nerve cell death is an excess of the chemical glutamate in the motor control pathways in the brain.

An excess of this chemical changes the way these pathways operate, and makes movement even less well controlled.

She said that stimulating ‘trigger points’ responsible for the release of a chemical that can kill brain cells can help thwart Alzheimer’s.

“The way we hope to achieve this is by stimulating protein targets on the nerve cell called metabotropic glutamate receptors. Certain types of these receptors, when stimulated, are known to prevent release of glutamate in other brain regions,” said Duty.

“We, and others, have now taken these ideas into regions relevant to Parkinson’s disease in the hope of reversing both the clinical signs and cell death associated with this condition.

“We, and others, have now taken these ideas into regions relevant to Parkinson’s disease in the hope of reversing both the clinical signs and cell death associated with this condition,” she added.

Duty said that current drugs could only treat the symptoms but not the underlying cause of the disease.

“They provide relief of symptoms by replacing the chemical, dopamine, which the dying cells would normally secrete in order to maintain proper control of movement,” she said.

“However, they do little to combat the ongoing progressive cell death meaning that symptoms get worse, higher doses of drug are needed to control the worsening symptoms, the result being appearance of disabling side-effects such as involuntary flailing limb movements and painful twisting of joints.

“Given the disease is progressive in nature, the continued death of cells in the substantia nigra leads to gradual worsening of symptoms and decline in patients’ quality of life over time.

“Finding drugs that can provide protection or repair to the dying cells – as well as relieve the clinical signs of Parkinson’s – is therefore a key area of interest in this field,” she added.

The study was presented at The British Pharmacological Society’s Summer Meeting in Edinburgh. (ANI)

How practice improves zebra finch’s singing performance

Washington, July 7 (ANI): A study on zebra finches conducted by neuroscientists at the Massachusetts Institute of Technology (MIT) has shed some light on how practice improves performance.

The researchers say that studying the chirps of zebra finches helped them determine that as these tiny songbirds fine-tune their songs, their brains initially store improvements in one brain pathway, before transferring this learned information to the motor pathway for long-term storage.

They believe that their findings may further scientists’ understanding of the complicated circuitry of the basal ganglia, brain structures that play a key role in learning and habit formation in humans.

The basal ganglia are also linked to disorders like Parkinson’s disease, obsessive-compulsive disorder and drug addiction.

“Birds provide a great system to study the fundamental mechanisms of how the basal ganglia contributes to learning. Our results support the idea that the basal ganglia are the gateway through which newly acquired information affects our actions,” said senior author Michale Fee, an investigator in the McGovern Institute for Brain Research at MIT.

The researchers point out that young zebra finches learn to sing by mimicking their fathers, whose song contains multiple syllables in a particular sequence.

Like the babbling of human babies, young birds initially produce a disorganized stream of tones, but after practicing thousands of times they master the syllables and rhythms of their father’s song.

Studies conducted in the past have identified two distinct brain circuits that contribute to this behaviour in zebra flinches.

A motor pathway is responsible for producing the song, and a separate pathway is essential for learning to imitate the father. The learning pathway, called the anterior forebrain pathway (AFP), has similarities to basal ganglia circuits in humans.

“For this study, we wanted to know how these two pathways work together as the bird is learning. So we trained the birds to learn a new variation in their song and then we inactivated the AFP circuit to see how it was contributing to the learning,” said first author Aaron Andalman, a graduate student in Fee’s lab.

With a view to training the birds, the research team monitored their singing and delivered white noise whenever a bird sang a particular syllable at a lower pitch than usual.

“The bird hears this unexpected noise, thinks it made a ‘mistake’, and on future attempts gradually adjusts the pitch of that syllable upward to avoid repeating that error. Over many days we can train the bird to move the pitch of the syllable up and down the musical scale,” Fee said.

On a particular day, after four hours of training in which the birds learned to raise the pitch, the researchers temporarily inactivated the AFP with a drug. The pitch immediately slipped back to where it had been at the start of that day’s training session – suggesting that the recently learned changes were stored within the AFP.

The research group, however, observed that over the course of 24 hours, the brain had transferred the newly learned information from the AFP to the motor pathway. The motor pathway was storing all of the accumulated pitch changes from previous training sessions. (ANI)

Parkinson’s medications may help treat extreme drug-resistant TB

Washington, July 3 (ANI): Two drugs that are commonly used to treat Parkinson’s disease have been found to be effective in treating extreme drug-resistant tuberculosis, say researchers at the University of California, San Diego.

They have discovered that the two commercially available drugs, entacapone and tolcapone, have the potential to treat multi-drug resistant and extensively drug resistant tuberculosis.

“We have computational, and experimental data to support this repositioning,” said Dr Philip E. Bourne, professor of pharmacology at UCSD’s Skaggs School of Pharmacy and Pharmaceutical Sciences and the principle investigator on the project.

“What is exciting about this finding is that the TB target, enzyme InhA, is already well known. But existing drugs are highly toxic and of completely different chemical structure than entacapone and tolcapone.

“Here we have drugs that are known to be safe and with suitable binding properties which can be further optimized to treat a completely different condition,” he added.

While working with the TB bacterium itself, they found that the active component in Comtan tablets (entacapone) is effective at inhibiting M.tuberculosis in concentrations well below a level that is toxic to cells.

“Although we have demonstrated in the lab that Comtan is active against M.tuberculosis, additional studies are required in order to transform it into an anti-tubercular therapeutic,” said Sarah L. Kinnings, a graduate student and lead author on the study.

“Given the continuing emergence of M.tuberculosis strains that are resistant to all existing, affordable drug treatments, the development of novel, effective and inexpensive drugs is an urgent priority,” she added.

The study appears in PLoS Computional Biology. (ANI)

Even tiny levels of carbon monoxide can damage fetal brain

Washington, June 26 (ANI): A new study has shown that exposure to even miniscule levels of carbon monoxide during pregnancy can have an adverse impact on fetal brain, resulting in permanent impairment.

“We expected the placenta to protect fetuses from the mother’s exposure to tiny amounts of carbon monoxide,” said John Edmond, professor emeritus of biological chemistry at the David Geffen School of Medicine at UCLA.

“But we found that not to be the case,” he added.

During the study, the researchers exposed pregnant rats to 25 parts per million carbon monoxide in the air, a level considered safe.

Dr. Ivan Lopez, UCLA associate professor of head and neck surgery, tested the rats’ litters 20 days after birth.

He found that rats born to animals who had inhaled the gas suffered chronic oxidative stress, a harmful condition caused by an excess of harmful free radicals or insufficient antioxidants.

“Oxidative stress damaged the baby rats’ brain cells, leading to a drop in proteins essential for proper function,” said Lopez.

“Oxidative stress is a risk factor linked to many disorders, including autism, cancer, Alzheimer’s, Parkinson’s, Lou Gehrig’s disease, multiple sclerosis and cardiovascular disease. We know that it exacerbates disease,” he added.

“We believe that the minute levels of carbon monoxide in the mother rats’ environment made their offspring more vulnerable to illness,” said Edmond.

“Our findings highlight the need for policy makers to re-examine the regulation of carbon monoxide,” the expert added.

Tobacco smoke, gas heaters, stoves and ovens all emit carbon monoxide, which can rise to high concentrations in well-insulated homes. Infants and children are particularly vulnerable to carbon monoxide exposure because they spend a great deal of time in the home.

The findings appear in journal BMC (BioMed Central) Neuroscience. (ANI)

Donate your computer’s idle time to find cure for HIV, Parkinson’s, breast cancer

Washington, June 21 (ANI): Your computer can be put to good use even when its not in use, for now it’s possible to donate the idle time to cutting-edge biomedical research aimed at finding a cure for HIV, Parkinson’s, arthritis, and breast cancer.

University of Delaware’s “Docking@Home” project, led by Michela Taufer, assistant professor of computer and information sciences, allows people to donate their computer’s idle time to perform scientific calculations that will aid in creating new and improved medicines to thwart these major diseases.

Taufer explained that researchers should create molecular models and simulate their interactions to reveal possible candidates for effective drugs, which could then be put under laboratory testing. And such a simulation is called “docking”.

As there are infinite combinations of molecules and their binding orientations, simulating them requires tremendous computing power.

Supercomputers often have a long waiting line or are too expensive to use for extended periods, said Taufer.

Thus, researchers have turned to citizen volunteers for help, which enables them to distribute the hundreds of thousands of computing tasks across a large number of computers.

Although the research is still in the validation stage, the process is aimed at studying new drugs.

“We are transforming a process in nature into computer steps-an algorithm,” explained Taufer.

To volunteer your computer’s idle time to do scientific calculations, it takes only a few simple steps highlighted on the project Web page (http://docking.cis.udel.edu/).

One can install a free, open-source software program called BOINC (Berkeley Open Infrastructure for Network Computing), developed at the University of California, and link up to the Docking Server at the University of Delaware to become part of the network.

The computer’s idle cycles are accessed automatically when it is not in use.

Currently, the 6,000 volunteers worldwide who currently are involved in UD’s Docking@Home project are contributing to the completion of some 30,000 docking tasks per day, said Taufer. (ANI)

New way to reduce tumour-risk factor in stem cell therapy unveiled

Washington, May 7 (ANI): Paving the way for advancement in the field of stem cell therapy, scientists have discovered a method to potentially eliminate the tumour-risk factor in utilizing human embryonic stem cells.

Human embryonic stem cells are theoretically capable of differentiation to all cells of the mature human body, and are hence defined as “pluripotent”.

The above capability, along with the ability to remain undifferentiated indefinitely in culture, make regenerative medicine using human embryonic stem cells a potential tool for the treatment of various diseases, including diabetes, Parkinson’s disease and heart failure.

However, the biggest hurdle in using stem cells is their tendency to grow into a specific kind of tumour, called teratoma, when they are implanted in laboratory experiments into mice.

And scientists have thought that the tumorigenic feature will be manifested upon transplantation to human patients as well.

Thus the development of tumours from embryonic stem cells is especially puzzling, keeping in mind that these cells start out as completely normal cells.

So, researchers at the Stem Cell Unit in the Department of Genetics at the Silberman Institute of Life Sciences at the Hebrew University analysed the genetic basis of tumour formation from human embryonic stem cells, and identified a key gene that is involved in this unique tumorigenicity.

The gene called survivin is expressed in most cancers and in early stage embryos, but it is almost completely absent from mature normal tissues.

The gene is especially highly expressed in undifferentiated human embryonic stem cells and in their derived tumours.

The researchers could neutralise the activity of survivin in the undifferentiated cells as well as in the tumours, and thus managed to initiate programmed cell death (apoptosis) in those cells.

The inhibition of this gene just before or after transplantation of the cells could minimize the chances of tumour formation.

But the researchers have warned that a combination of strategies may be needed to address the major safety concerns regarding tumour formation by human embryonic stem cells. (ANI)

Scientists identify ‘molecule trio’ that kills neurons in Parkinson’s

Washington, Apr 30 (ANI): In a novel study, researchers at Columbia University Medical Centre have identified a trio of molecules that are responsible for killing brain cells in Parkinson’s patients.

They have showed that three molecules – the neurotransmitter dopamine, a calcium channel, and a protein called alpha-synuclein – act together to kill the neurons.

The symptoms of Parkinson’s – including uncontrollable tremors and difficulty in moving arms and legs – are blamed on the loss of neurons from the substantia nigra region of the brain.

“Though the interactions among the three molecules are complex, the flip side is that we now see that there are many options available to rescue the cells,” said Dr Eugene Mosharov, associate research scientist and study’s author.

The researchers showed that neurons die because calcium channels lead to an increase of dopamine inside the cell; excess dopamine then reacts with alpha-synuclein to form inactive complexes; and then the complexes gum up the cell’s ability to dispose of toxic waste that builds up in the cell over time. The waste eventually kills the cell.

The neurons will survive if just one of the three factors is missing, said the researchers.

“It may be possible to save neurons and stop Parkinson’s disease by interfering with just one of the three factors,” Dr. Mosharov added.

The researchers hope that a drug already in clinical trials – which blocks the culprit calcium channel – may work to slow or stop the progression of the disease.

The study is published in journal Neuron. (ANI)

Pesticide exposure raises Parkinson’s risk

Washington, Apr 22 (ANI): Exposure to pesticides can increase the risk of Parkinson’s disease, say researchers.

Researchers from University of California, Los Angeles have found that fungicide maneb and herbicide paraquat can have detrimental effects on humans.

In a new epidemiological study of Central Valley residents who have been diagnosed with Parkinson’s disease, researchers found that years of exposure to the combination of these two pesticides increased the risk of Parkinson’s by 75 percent.
urther, for people 60 years old or younger diagnosed with Parkinson’s, earlier exposure had increased their risk for the disease by as much as four- to six-fold.

Reporting in the April 15 issue of the American Journal of Epidemiology, Beate Ritz, professor of epidemiology at the UCLA School of Public Health, and Sadie Costello, a former doctoral student at UCLA who is now at the University of California, Berkeley, found that Central Valley residents who lived within 500 meters of fields sprayed between 1974 and 1999 had a 75-percent increased risk for Parkinson’s.

In addition, people who were diagnosed with Parkinson’s at age 60 or younger were found to have been at much higher risk because they had been exposed to maneb, paraquat or both in combination between 1974 and 1989, years when they would have been children, teens or young adults.

The researchers enrolled 368 longtime residents diagnosed with Parkinson’s and 341 others as a control group.

Parkinson’s disease is a degenerative disorder of the central nervous system that often impairs motor skills, speech and other functions. It has been reported to occur at high rates among farmers and in rural populations, contributing to the hypothesis that agricultural pesticides may be partially responsible.

“Because pesticides applied from the air or ground may drift from their intended treatment sites – with measurable concentrations subsequently detected in the air, in plants and in animals up to several hundred meters from application sites – accurate methods of estimating environmental exposures in rural communities have long been sorely needed,” said Ritz, the study’s senior author and vice chair of the School of Public Health’s epidemiology department.

So Ritz, Costello and colleague Myles Cockburn from the University of Southern California, developed a geographic information system-based tool that estimated human exposure to pesticides applied to agricultural crops. This GIS tool combined land-use maps and pesticide-use reporting data from the state of California. Each pesticide-use record includes the name of the pesticide’s active ingredient, the amount applied, the crop, the acreage of the field, the application method and the date of application.

Research subjects were recruited between 1998 to 2007; telephone interviews were conducted to obtain their demographic and exposure information.

Detailed residential history forms were mailed to subjects in advance of their interviews and were reviewed in person or over the phone. The researchers recorded and added lifetime residential histories and estimated ambient exposures into the system for all historical addresses at which participants had resided between 1974 and 1999, the period covered by the pesticide-use data.

“The results confirmed two previous observations from animal studies. One, that exposure to multiple chemicals may increase the effect of each chemical. That’s important, since humans are often exposed to more than one pesticide in the environment. And second, that the timing of exposure is also important,” Ritz said. (ANI)